Table 1.
Patient characteristics and survival.
| Characteristics | # Cases | % Pts | MS ( 95% CI ) | % of Overall Survival (95% CI) | P Value | |||
|---|---|---|---|---|---|---|---|---|
| months | 1 Year | 2 Year | 3 Year | 5 Year | ||||
| Gender | <0.0001 | |||||||
| Male | 156,721 | 54.3 | 7 (na, na) | 36.9 (36.6, 37.1) | 23.1 (22.9, 23.3) | 17.3 (17.1, 17.5) | 12.2 (12.0, 12.4) | |
| Female | 131,949 | 45.7 | 10 (9,10) | 43.8 (43.6, 44.1) | 30.2 (30.0, 30.5) | 23.8 (23.5, 24.0) | 17.2 (17.0, 17.5) | |
| Race | <0.0001 | |||||||
| White | 238,147 | 82.5 | 8 (na, na) | 40.1 (39.9, 40.3) | 26.6 (26.4, 26.8) | 20.5 (20.3, 20.6) | 14.8 (14.6, 14.9) | |
| Black | 31,100 | 10.8 | 7 (7, 8) | 36.8 (36.2, 37.3) | 22.3 (21.8, 22.8) | 16.8 (16.3, 17.2) | 11.7 (11.2, 12.1) | |
| Other/Unk | 19,423 | 6.7 | 10 (na,na) | 44.7 (44.0, 45.5) | 29.8 (29.1, 30.5) | 22.8 (22.1, 23.4) | 15.5 (14.9, 16.1) | |
| Age | <0.0001 | |||||||
| <65 | 99,495 | 34.5 | 11 (na, na) | 47.0 (46.7, 47.3) | 32.0 (31.7, 32.3) | 25.7 (25.4, 26.0) | 19.6 (19.4, 19.9) | |
| ≥65 | 189,175 | 65.5 | 7 (na, na) | 36.4 (36.2, 36.6) | 23.3 (23.1, 23.5) | 17.4 (17.2, 17.6) | 11.7 (11.5, 11.9) | |
| Marital Status | <0.0001 | |||||||
| Married | 147,399 | 51.1 | 10 (na, na) | 43.8 (43.6, 44.1) | 29.5 (29.2, 29.7) | 23.1 (22.8, 23.3) | 16.9 (16.7, 17.1) | |
| Not Married | 129,918 | 45.0 | 7 (na, na) | 35.8(35.6, 36.1) | 22.8 (22.6, 23.1) | 17.1 (16.8, 17.3) | 11.8 (11.6, 12.0) | |
| Unknown | 11,353 | 3.9 | 8 (7, 8) | 39.1 (38.1, 40.0) | 25.8 (24.9, 26.7) | 19.6 (18.8, 20.4) | 13.9 (13.2, 14.7) | |
| AJCC Stage | <0.0001 | |||||||
| Stage I | 53,764 | 18.6 | 49 (48, 50) | 78.7 (78.3, 79.0) | 65.7 (65.3, 66.2) | 56.9 (56.4, 57.3) | 45.2 (44.7, 45.8) | |
| Stage II | 10,937 | 3.8 | 27 (26, 29) | 71.0 (70.1, 71.9) | 53.3 (52.3, 54.3) | 42.3 (41.2, 43.3) | 29.8 (28.7, 30.9) | |
| Stage III | 74,570 | 25.8 | 9 (9, 10) | 41.7 (41.3, 42.1) | 24.0 (23.7, 24.3) | 16.6 (16.3, 16.9) | 10.6 (10.4, 10.9) | |
| Stage IV | 117,228 | 40.6 | 4 (na, na) | 19.7 (19.5, 20.0) | 8.5 (8.3, 8.7) | 4.9 (4.7, 5.0) | 2.4 (2.3, 2.5) | |
| SEER Stage | <0.0001 | |||||||
| Localized | 51,802 | 18.0 | 45 (44, 46) | 76.7 (76.5, 77.2) | 63.5 (63.0, 63.9) | 54.9 (54.4, 55.4) | 43.5 (43.0, 44.0) | |
| Regional | 69,650 | 24.1 | 15 (15, 16) | 55.7 (55.3, 56.1) | 37.5 (37.1, 37.9) | 28.5 (28.1, 28.9) | 19.9 (19.5, 20.2) | |
| Histology | <0.0001 | |||||||
| Adenocarcinoma | 98,141 | 34.0 | 10 (na, na) | 45.5 (45.1, 45.8) | 31.0 (30.7, 31.3) | 24.1 (23.8, 24.4) | 17.0 (16.7, 17.3) | |
| Squamous Ca | 60,057 | 20.8 | 10 (na, na) | 44.9 (44.5, 45.3) | 29.0 (28.6, 29.4) | 21.9 (21.5, 22.2) | 15.6 (15.3, 16.0) | |
| Large Cell Ca | 11,669 | 4.1 | 8 (7,8) | 36.5 (35.6, 37.4) | 22.5 (21.7, 23.3) | 17.4 (16.7, 18.2) | 12.7 (12.0, 13.4) | |
| Carcinoid | 3,584 | 1.2 | N/A | 93.8 (93.0, 94.6) | 90.6 (89.6, 91.6) | 87.8 (86.4, 88.8) | 82.6 (81.1, 84.1) | |
| Others | 115,219 | 39.9 | 6 (na, na) | 31.7 (31.4, 31.9) | 19.5 (19.2, 19.7) | 14.4 (14.2, 14.6) | 10.0 (9.8, 10.2) | |
| All Patients | 288,670 | 100 | 8 (na, na) | 40.0 (39.9, 40.2) | 26.3 (26.2, 26.5) | 20.2 (20.1, 20.4) | 14.5 (14.3, 14.7) | |
Note: MS=median survival, pt= patients, CI= confidence interval, ca= carcinoma, N/A= an interval that was too narrow to be computable.